Back to Journals » Journal of Inflammation Research » Volume 14

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer

Total article views   HTML views PDF downloads Totals
6,723 Dovepress* 5,942+ 289 6,231
PubMed Central* 781 154 935
Totals 6,723 443 7,166
*Since 22 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 5 5

View citations on PubMed Central and Google Scholar